Worldwide Report Coagulation Lot Exp 31 Oct 2018

Similar documents
Insights on the Quality of Coagulation Testing

MEASUREMENT OF ANTICOAGULANT EFFECTS OF NEW ORAL ANTICOAGULANTS PRACTICAL ASPECTS

Individual Lab Report Ci-Trol Nov,2016. Abnormal Fibrinogen (mg/dl) Abnormal Fbg Control - Lot# LFC Your Lab

ECAT FOUNDATION REPORT

Beyond Clotting Time Clot Waveform Analysis (CWA)

Keywords: anticoagulants, blood coagulation, blood coagulation tests, coagulation, dabigatran, drug monitoring. Introduction

Il laboratorio: verso una migliore definizione dei test

Use of PSI on CS instruments

Use of PSI on CS instruments

prevent its recurrence. The FDA is reviewing possible deficiencies in the manufacturer s reagent package labeling.

ECAT FOUNDATION REPORT

Determination of APTT factor sensitivity the misguiding guideline

Note to the Reader. To make navigation easier, this PDF contains internal hyperlinks and also includes links to online resources

Comparison of Samples Obtained From 3.2% Sodium Citrate Glass and Two 3.2% Sodium Citrate Plastic Blood Collection Tubes Used in Coagulation Testing

A Percent Correction Formula for Evaluation of Mixing Studies

Vitamin K antagonist (VKA) therapy is routinely

Third Party Controls for Your Dade Behring Systems

Manufacturer Report for Siemens Unassayed Chemistry Lot Exp 30 Jun 2018

Clinical Study Synopsis

The study has been approved by Ethics Commission. Informed consent has been given by all participants.

EARLY ONLINE RELEASE

Coagulation and Transfusion Medicine

Interference of C-reactive protein with clotting times

How Good is your INR? The Use of Certified Plasmas in PT/INR Testing. INR System. How Good is your INR? Outline

URGENT FIELD SAFETY NOTICE IMMEDIATE ACTION REQUIRED

Evaluation Report. Eurolyser PT (INR) test kit (ST0180) on CUBE and smart analysers

Cardiac Assessment Controls

New Anticoagulants: Laboratory Monitoring?? Dr Steve Kitchen Sheffield Haemostasis and Thrombosis centre UK

Customer Bulletin. Questions/Comments? Please call Customer Service at (Direct) or (Toll-free inside USA).

General approach to the investigation of haemostasis. Jan Gert Nel Dept. of Haematology University of Pretoria 2013

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Bio-Rad Laboratories. Cardiac Assessment Controls. Value Assigned for Clinical Laboratory and Point of Care Test Systems

Christopher M. Lehman, MD, 1,3 Lori W. Wilson, MT(ASCP), MS, 3 and George M. Rodgers, MD, PhD 1-3. Abstract

Y. ZHAO, G. LV SUMMARY

MINISTRY OF HEALTH AND QUALITY OF LIFE. Executive Summary of Bid Evaluation Report

We are writing to inform you about an issue concerning your CoaguChek system and test strips. Please read this information carefully.

6 semanas de embarazo. Critical pt inr levels. Inicio / Embarazo / 6 semanas de embarazo

fritsmafactor.com Coag QA: Why are we Different? Prothrombin Time 1980: PT Ratio Based on MRI PTR = PTpatient PTMRI

HEMATOLOGY AND COAGULATION ANALYTIC PROTOCOLS

The certification of reference plasmas for the prothrombin time BCR-628 (Abnormal Plasma 2) BCR-630 (Normal Plasma) BCR-631 (Abnormal Plasma 1)

ACTICLOT dpt REF 824. IVD C i 2 l. Dilute Prothrombin Time Test for the Determination of Lupus Anticoagulants (LA) (CPT Code No.

Cardiac Assessment Controls A critical element of reliable cardiac testing

Multicenter evaluation of the CoaguChek Prothrombin Time (PT) Test on the CoaguChek Pro II meter White paper

P re-analytical conditions are very important in laboratory assessment of hemostatic and coagulation systems

HEMOCHRON. Whole Blood Coagulation Systems

The influence of laboratory-induced MELD score differences on liver allocation: more reality than myth

EQAS. Hemoglobin Program (BC80) Cycle 12: December 2014 December 2015 Sample No: 1 Sample Date: 17 Dec 14. Exceptions. Customer Information

Presented by Marcelo Cardona, MT(ASCP) Johns Hopkins University

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Cher t s e y Lan e, Stai ne s - u pon-thames, TW18 3H R, UK

Internal Quality Control in the Haemostasis laboratory. Dr Steve Kitchen Sheffield Haemophilia and Thrombosis centre & UK NEQAS Blood Coagulation

Accepted: 12 November 2018

Improved Distinction of Factor V Wild-Type and Factor V Leiden Using a Novel Prothrombin-Based Activated Protein C Resistance Assay

Primary Exam Physiology lecture 5. Haemostasis

Behzad Poopak, DCLS PhD

Alere INRatio 2 METHOD AND SAMPLE COLLECTION

Influence of Blood Lipids on Global Coagulation Test Results

Koostas: Anneli Aus Laboriarst Allkiri Ees- ja perekonnanimi Ametikoht kuupäev

Monitoring target-specific oral anticoagulants

Characterisation of Direct Acting Oral Anticoagulants and Their Pharmacodynamics on Thrombin Generation and Coagulation Parameters.

1990s DTI. 1980s LMWH

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Warfarin Does Not Interfere with Lupus Anticoagulant Detection by Dilute Russell s Viper Venom Time

Causes of isolated prolonged activated partial thromboplastin time in an acute care general hospital

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

The APC of Coag Back to Basics Troubleshooting

The LaboratoryMatters

CLINICAL FELLOWSHIP PROGRAM IN COAGULATION

Revalidation of CoaguChek XS Plus System for INR Monitoring in Taiwanese Patients: Effects of Clinical and Genetic Factors

Commentary by R. Little, Ph.D., NGSP Network Coordinator for the NGSP Steering Committee

Comparison of Three Methods for Measuring Factor VIII Levels in Plasma

Introduction to coagulation and laboratory tests

Commentary by R. Little, Ph.D., NGSP Network Coordinator for the NGSP Steering Committee

Phospholipid composition controls thromboplastin sensitivity to individual clotting factors

Effects of preanalytical frozen storage time and temperature on screening coagulation tests and factors VIII and IX activity

Thrombosis. Clinical Chemistry 51: (2005) Hemostasis and

Instruments smart solutions & service IGZ Instruments AG Räffelstrasse 32 CH 8045 Zürich

Collection of Blood Specimens by Venipuncture for Plasma-Based Coagulation Assays Necessity of a Discard Tube

HIGH FACTOR VIII, VON WILLEBRAND FACTOR, AND FIBRINOGEN LEVELS AND RISK

DR NAGY VALÉRIA RETINAL VASCULAR DISEASES: THE RARE FORMS OF THROMBOPHILIA.

Evaluation of the Precision and Accuracy of the INRatio 2 Prothrombin Time (PT) Monitoring System

laboratory monitoring of Direct Oral Anticoagulant: who, when and how Dr. Malake Naboulsi Hôpital Albert Haykel Laboratoire d hématologie.

Clinically Relevant Differences in Prothrombin Time and INR Values Related to Blood Sample Collection in Plastic vs Glass Tubes

QuickVet Diagnostic System

Downloaded from journal.qums.ac.ir at 6: on Monday September 3rd 2018

Stability of prothrombin time and activated partial thromboplastin time tests under different storage conditions

Clinically Relevant Differences in Prothrombin Time and INR Values Related to Blood Sample Collection in Plastic vs Glass Tubes

CME/SAM. Influence of Coagulation and Anticoagulant Factors on Global Coagulation Assays in Healthy Adults

Compositional Differences in Commercially Available Prothrombin Complex Concentrates

Disclosures. Point of Care Testing (POCT) for Anticoagulation Monitoring. Point of Care Anticoagulation Monitoring. Questions.

Plasma Levels of Protein Z and Antiphospholipid Protein Antibodies in Patients with Ischemic Stroke

approach Local INR correction: justification for a simplified Results-All system groups required correction, logarithm of local prothrombin time

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Blood Collection Additives

College of American Pathologists (CAP) GH2 Survey Data: (updated 12/09) 2009 GH2-B (fresh pooled samples) * = NGSP certified at the time of the survey

HEMOSTASIS Quality Time saving Economy Practicability Quality assurance Precision

Laboratory Automation and Intra- Laboratory Turnaround Time: Experience at the University Hospital Campus Bio-Medico of Rome

Normalised Ratio. Papers. Effect of thromboplastin and coagulometer interaction on the precision of the International

Effects of saline or albumin resuscitation on standard coagulation tests

Elevated Factor XI Activity Levels Are Associated With an Increased Odds Ratio for Cerebrovascular Events

I know my value CoaguChek XS Pro system

Transcription:

April 0 Worldwide Report Coagulation Lot 780 Exp Oct 08 Activated Partial Thromboplastin Time (APTT) Diagnostica Stago C.K. Prest Seconds 0.7 0.89.8 9 0.7 0.89.8 9 8.8..7 8.8..7 9.90 0.97.0 9.90 0.97.0 Method Group Diagnostica Stago C.K. Prest 0.7 0.89.8 9 0.7 0.89.8 9 8.8..7 8.8..7 9.90 0.97.0 9.90 0.97.0 Activated Partial Thromboplastin Time (APTT) Diagnostica Stago STA Cephascreen Seconds Bioserv Diagnostics.8. 0..7.9 9..7. 7..9.9 8. Method Group Diagnostica Stago STA Cephascreen.8. 0..7.9 9..7. 7..9.9 8. Activated Partial Thromboplastin Time (APTT) Diagnostica Stago STA PTT Automate Seconds.8.0.9 0.8.0.9 0 77.0.7. 0 77.0.7. 0 9.0 8.0 8.8 9 9.0 8.0 8.8 9 Method Group Diagnostica Stago STA PTT Automate.8.0.9 0.8.0.9 0 77.0.7. 0 77.0.7. 0 9.0 8.0 8.8 9 9.0 8.0 8.8 9 Activated Partial Thromboplastin Time (APTT) Helena APTT Ratio Helena Analyzer. 0.007 0. Method Group Helena APTT. 0.007 0. The statistics in this report are derived from user supplied data and are provided by Bio Rad Laboratories as a service to its customers. Such action does not imply support of reported analytes and test methods. Refer to the package insert for specific analyte claims and stability information. Qualitative percentages may not add up to 00 due to rounding. Peer group statistics contained in this report may not be used without the expressed written consent of Bio Rad Laboratories. Copyright 0 Bio Rad Laboratories, Inc. Generated May 0 :0: Page

Coagulation Lot 780 Exp Oct 08 April 0 Activated Partial Thromboplastin Time (APTT) Helena APTT Seconds Helena Analyzer 7.0 0. 0. Method Group Helena APTT 7.0 0. 0. Activated Partial Thromboplastin Time (APTT) IL HemosIL APTT SP (liquid) Seconds Instrumentation Laboratory ACL 8000, 9000, 0000, Elite/Pro.78.9..78.9. 7...0 7...0 7.7 0.8. 7.7 0.8. Instrumentation Laboratory ACL TOP 00.0..7.0..7..8...8. Method Group IL HemosIL APTT SP (liquid)...0 7...0 7 7... 0 7... 0 7.7 0.8. 7.7 0.8. Activated Partial Thromboplastin Time (APTT) IL HemosIL SynthASil Seconds Instrumentation Laboratory ACL 8000, 9000, 0000, Elite/Pro 8.0..0 9 8.0.7. 8.0.9. 8 8..0. Method Group IL HemosIL SynthASil 8.0..0 9 8.0.7. 8.0.9. 8 8..0. Activated Partial Thromboplastin Time (APTT) Siemens Actin FS Ratio 0.980 0.00.0 0.980 0.00.0.7 0.0..7 0.0. Method Group Siemens Actin FS 0.980 0.00.0 0.980 0.00.0.7 0.0..7 0.0. Copyright 0 Bio Rad Laboratories, Inc. Generated May 0 :0: Page

Coagulation Lot 780 Exp Oct 08 April 0 Activated Partial Thromboplastin Time (APTT) Siemens Actin FS Seconds.77 0..0.77 0..0.8.7.7 9.8.7.7 9.8 0.00..8 0.00.. 0.8.. 0.8. Sysmex CA 0 8.7 0.0. 0 8.7 0.0. 0 8.0 0.90. 0 8.0 0.90. 0 Method Group Siemens Actin FS.9.9. 7.9.9. 7 7.9..0 70 7.9..0 70 Activated Partial Thromboplastin Time (APTT) Siemens Actin FSL Seconds.7 0.77.7 8.77 0.. 0.8..7.9.0 9.8 9.0.0. 9.0.0. Method Group Siemens Actin FSL.7 0.77.7 8.77 0.. 0.8..7.9.0 9.8 9.0.0. 9.0.0. Activated Partial Thromboplastin Time (APTT) Siemens Pathromtin SL Seconds.8. 0..8. 0. 9..7.8 9..7.8 Sysmex CS 000i/00i..8 9.9 8..8 9.9 8 9.8.9. 8 9.8.9. 8 Method Group Siemens Pathromtin SL.7. 0..7. 0. 9.8.08. 9.8.08. Copyright 0 Bio Rad Laboratories, Inc. Generated May 0 :0: Page

Coagulation Lot 780 Exp Oct 08 April 0 Activated Partial Thromboplastin Time (APTT) Trinity Biotech Triniclot aptt S Seconds. 0.878. 897 7. 0.879. 900 7 8.7..7 0 9 8...7 0 9 Trinity Biotech AMAX Series 7.8 0.80. 7.8 0.80..98.0.0.98.0.0 Method Group Trinity Biotech Triniclot aptt S. 0.88. 90 8. 0.88. 90 8 8.0.9.7 07 0 8.9.9.7 00 0 Fibrinogen Calculated mg/dl 7.8.7.8 98 7.8.7.8 98 9.9.87. 9 9.9.87. 9 Alternate Formulation/Standardization 0.0 0.00. Method Group Calculated 7.8.7.8 98 7.8.7.8 98 9.9.87. 9 9.9.87. 9 Fibrinogen Electromechanical mg/dl 0.8.9. 0.8.9... 9.9.. 9.9 0.0.8. 0.0.8. Stago STA Fibrinogen 7.0 8.9.7 7.0 8.9.7...... 0. 0.70 0.7 0. 0.70 0.7 Method Group Electromechanical 0.7 0.9. 7 0.7 0.9. 7.. 9.8 8.. 9.8 8 0..80.7 8 0..80.7 8 Copyright 0 Bio Rad Laboratories, Inc. Generated May 0 :0: Page

Coagulation Lot 780 Exp Oct 08 April 0 Fibrinogen Immunoturbidimetric mg/dl Helena Analyzer 97.0 7.78 8.0 Instrumentation Laboratory ACL TOP 00 0. 9.79. 0. 9.79..8. 8..8. 8. Method Group Immunoturbidimetric 0. 9.79. 0. 9.79..8. 8..8. 8. 97.0 7.78 8.0 Fibrinogen Photo Optical mg/dl.........7...7 0..8.0 0..8.0 Instrumentation Laboratory ACL 8000, 9000, 0000, Elite/Pro 0.9.07.8 0 0.9.07.8 0 7. 8.0.8 7. 8.0.8 0. 0.000 0.0 0. 0.000 0.0.9...9...8.0 9.0.8.0 9.0 90. 9.0.7 7 90. 9.0.7 7 8. 8.7. 7 8. 8.7. 7 8.0.. 9 8.0.. 9 Sysmex CS 000i/00i 7..8 8.0 7 7..8 8.0 7.0.9.9 7.0.9.9 7 Method Group Photo Optical 0.7. 0. 9 0.7. 0. 9. 0.0. 07 9. 0.0. 07 9 89.0 8.0 9. 89.0 8.0 9. Copyright 0 Bio Rad Laboratories, Inc. Generated May 0 :0: Page

Coagulation Lot 780 Exp Oct 08 April 0 Prothrombin Time (PT) ISI<=. Diagnostica Stago STA Neoplastin R INR.0 0.0..0 0.0..8 0.0..8 0.0..77..77. Method Group Diagnostica Stago STA Neoplastin R.0 0.0..0 0.0..8 0.0..8 0.0..77..77. Prothrombin Time (PT) ISI<=. Diagnostica Stago STA Neoplastin R Seconds. 0.7.. 0.7..8 0.88..8 0.88..8.8..8.8. Method Group Diagnostica Stago STA Neoplastin R. 0.7.. 0.7..8 0.88..8 0.88..8.8..8.8. Prothrombin Time (PT) ISI<=. Diagnostica Stago STA Neoplastine CI Plus Seconds Bioserv Diagnostics.8 0.70..9 0.8.8. 0.900.0.88.9.8 8.8 0.8.8.8 0.8.7 9..09.7 0 9..09.7 0 0.0.7. 0 0.0.7. 0 Method Group Diagnostica Stago STA Neoplastine CI Plus.87 0.9.8 7.9 0.8. 9... 7 9... 8 0.0.7. 0 0.0.7. 0 Prothrombin Time (PT) ISI<=. IL HemosIL RecombiPlasTin Seconds Instrumentation Laboratory ACL 8000, 9000, 0000, Elite/Pro. 0.7.9. 0.7.9 9.8.7.7 9.8.7.7 Method Group IL HemosIL RecombiPlasTin. 0.7.9. 0.7.9 9.8.7.7 9.8.7.7 Copyright 0 Bio Rad Laboratories, Inc. Generated May 0 :0: Page

Coagulation Lot 780 Exp Oct 08 April 0 Prothrombin Time (PT) ISI<=. IL HemosIL RecombiPlasTin G Seconds Instrumentation Laboratory ACL 8000, 9000, 0000, Elite/Pro 0.88 0.98. 7 0.8 0..9.70..8 0.70..8 0.00 0.9.7 9.09 0.809. Instrumentation Laboratory ACL TOP 00 0.9 0.70. 0.9 0.70..0 0.800.0.0 0.800.0 Method Group IL HemosIL RecombiPlasTin G 0.89 0.88. 0.8 0..9 7.9...9...00 0.9.7 9.09 0.809. Prothrombin Time (PT) ISI<=. Siemens Innovin INR.0 0.09.8.0 0.09.8.07 0.07..07 0.07. Method Group Siemens Innovin.0 0.09.8.0 0.09.8.07 0.07..07 0.07. Prothrombin Time (PT) ISI<=. Siemens Innovin Seconds 0.7 0.8. 8 0.78 0.0.0 0.88 0..7.. 9..8 0.77..8 0.77. Method Group Siemens Innovin 0.7 0.8. 8 0.78 0.0.0 0.88 0..7.. 9..8 0.77..8 0.77. Prothrombin Time (PT) ISI<=. Siemens Thromborel S % 9.9..9 9.9..9. 0... 0.. Method Group Siemens Thromborel S 9.9..9 9.9..9. 0... 0.. Copyright 0 Bio Rad Laboratories, Inc. Generated May 0 :0: Page 7

Coagulation Lot 780 Exp Oct 08 April 0 Prothrombin Time (PT) ISI<=. Siemens Thromborel S INR Helena Analyzer.0 0.0 0.7.0 0.0..0 0.0...7..7.0 0.07..0 0.07..8 0.09..8 0.09. Method Group Siemens Thromborel S.0 0.0. 7.0 0.0. 7.07 0.7 7..07 0.7 7..0 0.0 0.7 Prothrombin Time (PT) ISI<=. Siemens Thromborel S Seconds.7 0.9..7 0.9..0 0.779..0 0.779.. 0.9.7 7. 0.9.7 7.0.8 7. 7.0.8 7. 7 Sysmex CA 0.0 0.80.8.0 0.80.8.0.07..0.07. Sysmex CS 000i/00i.7 0.0. 9.7 0.0. 9.7.0. 9.7.0. 9 Method Group Siemens Thromborel S.7 0.9.8 7.7 0.9.8 7.7.7. 7.7.7. 7 Copyright 0 Bio Rad Laboratories, Inc. Generated May 0 :0: Page 8

Coagulation Lot 780 Exp Oct 08 April 0 Prothrombin Time (PT) ISI<=. Tcoag TriniCLOT PT Excel S Seconds Trinity Biotech AMAX Series. 0.0.. 0.0..8.00.0.8.00.0 Method Group Tcoag TriniCLOT PT Excel S. 0.0.. 0.0..8.00.0.8.00.0 Thrombin Time All methods Seconds Alternate Formulation/Standardization 7.0 0.0 0.7 Method Group All methods Thrombin Time Electromechanical Seconds.9 0.79.7.9 0.79.7...... 8.90 0.8.0 8.90 0.8.0 Method Group Electromechanical.9 0.79.7.9 0.79.7...... 8.90 0.8.0 8.90 0.8.0 Thrombin Time Photo Optical Seconds.8 0..7.8 0..7.8 0.80.7.8 0.80.7 7.80 0..0 7.80 0..0 Instrumentation Laboratory ACL 8000, 9000, 0000, Elite/Pro.7.07. 0.7.07. 0 9.9.0.8 9.9.0.8..8...8. 0.9 0.8.0 0.9 0.8.0 9.0.. 9.0.. Copyright 0 Bio Rad Laboratories, Inc. Generated May 0 :0: Page 9

Coagulation Lot 780 Exp Oct 08 April 0 Thrombin Time Photo Optical Seconds Sysmex CA 0 Siemens Thromboclotin.9 0.700..7 0.0.8 Method Group Photo Optical 8.7.0.0 7 9 8.7.97 0.8 89 0 8..0 0.7 7 0.8.7. 89.9.8. 8.9.8. 8 Copyright 0 Bio Rad Laboratories, Inc. Generated May 0 :0: Page 0